45
Participants
Start Date
December 31, 2016
Primary Completion Date
August 31, 2022
Study Completion Date
November 30, 2023
VDC-IE x2
"Week 1, 5, 9 and week 13:~* Vincristine, IV, D1, 1.5mg/m²~* Doxorubicine, IV, D1-D2, 37.5mg/m²~* Cyclophosphamide, IV, D1, 1.2g/m²~Week 3, 7, 11 and week 15:~* Ifosfamide, IV, D15 to D19, 1.8g/m²/d~* Etoposide, IV, D15 to D19, 100mg/m²/d"
VDC-IE
"Week 1 and week 5:~* Vincristine, IV, D1, 1.5mg/m²~* Doxorubicine, IV, D1-D2, 37.5mg/m²~* Cyclophosphamide, IV, D1, 1.2g/m²~Week 3, and week 7:~* Ifosfamide, IV, D15 to D19, 1.8g/m²/d~* Etoposide, IV, D15 to D19, 100mg/m²/d"
TEMIRI
"Week 9, 12, 15 and week 18:~* Temozolomide, PO, D1 to D5, 150mg/m²/d~* Irinotecan, IV, D1 to D5, 50mg/m²/d"
Consolidation BuMel
"After induction phase and local treatment (surgery and/or radiotherapy) and before PBSC:~* Busulfan, IV, D-5 to D-2, dosa according to the weight~* Melphalan, IV, D-1, 140 mg/m²~Peripheral Blood Stem Cell infusion:~\- PBSC infusion, D0, at least 3.10\^6 CD34/kg"
Maintenance
"\* 1st year : VC~* Vinblastine, IV, 3mg/m², once a week (except during radiotherapy: 1mg/m², 3 times a week)~* Cyclophosphamide, PO, 25mg/m² continuously"
Local treatment by surgery
Surgical excision of whole site of the primary tumour and metastatic sites (outside pulmonary sites) can take place before or after the high dose consolidation chemotherapy. Radiotherapy can be added
Local treatment by radiotherapy
Radiotherapy of whole site of the primary tumour and metastatic sites (outside pulmonary sites) can take place before or after the high dose consolidation chemotherapy
Marseille Chu, Marseille
Toulouse Chu, Toulouse
TOULOUSE Institut Claudius Regaud, Toulouse
Bordeaux Chu, Bordeaux
CHRU Montpellier - Hôpital A. de Villeneuve, Montpellier
CHU Hôpital Sud, Rennes
CHU Grenoble Alpes, Grenoble
Nantes Chu, Nantes
Nancy Chu, Vandœuvre-lès-Nancy
NANCY Institut de Cancérologie de Lorraine, Vandœuvre-lès-Nancy
LILLE Centre Oscar Lambret, Lille
Strasbourg Chu, Strasbourg
LYON Centre Léon Bérard, Lyon
PARIS Institut Curie, Paris
PARIS Trousseau, Paris
VILLEJUIF Institut Gustave Roussy, Villejuif
Chr Felix Guyon, La Réunion
UNICANCER
OTHER
Institut Curie
OTHER